Inroduction
Nephrotic syndrome is one of the bcommon cause of hospitalization among children.
Incidence of the condition is 2 to7 per1000.
It is more common in male child.
Mean age of occurrence is 2 to 5 years.
It is a symptom complex manifested by massive oedema, hypoalbuminemia, marked albuminuria and hyperlipidemia
Classification
Congenital nephrotic syndrome
Idiopathic or primary nephrotic syndrome
Secondary nephrotic syndrome
Congenital nephrotic syndrome
It is rare but serious and fatal problem usually associated with other congenital abnormalities of kidney.
It is inherited as autosomal recessive disease.
Severe renal insufficiency and urinary infections along with this condition result is poor prognosis.
Idiopathic or primary nephrotic syndrome
It is the most common type(about 90%) and regarded as autoimmune phenomenon as it responds to immunosuppressive therapy.
Subgroup of this type◦ Minimal change nephrotic syndrome(85%)◦ Proliferative nephrotic syndrome(5%)◦ Focal sclerosis nephrotic syndrome(10%)
Let's learn the pharmacology related to nephrotic syndrome - features of nephrotic syndrome with underlying mechanisms, objectives of treatment, and management of the nephrotic syndrome.
simlpe approach to anemia in children , how to diagnose anemia in kids ,types of anemias ,causes of anemia , iron deficeincy anemia, hemolytic anemias , laboratory tests in anemia ,
Definition of neonatal sepsis,type of neonatal sepsis ,early onset neonatal sepsis,late onset neonatal sepsis,Pathophysiology of neonatal sepsis,,sign and symptoms of neonatal sepsis, diagnosis of neonatal sepsis,management of neonatal sepsis, antibiotic used for neonatal sepsis,prevention of neonatal sepsis, prognosis of neonatal sepsis ,and A summary
Nephrotic syndrome is a kidney disorder that causes your body to pass too much protein in your urine. Nephrotic syndrome is usually caused by damage to the clusters of small blood vessels in your kidneys that filter waste and excess water from your blood.
This presentation focuses on Acute Bacterial Meningitis.
Viral and fungal cause is mentioned but focus is on bacterial meningitis in Pediatrics Patient.
Feel free to correct if there is any error.
Refer to other reference books for clarity.
Let's learn the pharmacology related to nephrotic syndrome - features of nephrotic syndrome with underlying mechanisms, objectives of treatment, and management of the nephrotic syndrome.
simlpe approach to anemia in children , how to diagnose anemia in kids ,types of anemias ,causes of anemia , iron deficeincy anemia, hemolytic anemias , laboratory tests in anemia ,
Definition of neonatal sepsis,type of neonatal sepsis ,early onset neonatal sepsis,late onset neonatal sepsis,Pathophysiology of neonatal sepsis,,sign and symptoms of neonatal sepsis, diagnosis of neonatal sepsis,management of neonatal sepsis, antibiotic used for neonatal sepsis,prevention of neonatal sepsis, prognosis of neonatal sepsis ,and A summary
Nephrotic syndrome is a kidney disorder that causes your body to pass too much protein in your urine. Nephrotic syndrome is usually caused by damage to the clusters of small blood vessels in your kidneys that filter waste and excess water from your blood.
This presentation focuses on Acute Bacterial Meningitis.
Viral and fungal cause is mentioned but focus is on bacterial meningitis in Pediatrics Patient.
Feel free to correct if there is any error.
Refer to other reference books for clarity.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. Outlines:
1. Inroduction
2. Classification
3. pathophysiology
4. Clinical features
5. Complications
6. Demographic Details
7. History of patient illness
8. plan of therapy
9. Laboratory tests
3. Inroduction
Nephrotic syndrome is one of the bcommon cause of hospitalization
among children.
Incidence of the condition is 2 to7 per1000.
It is more common in male child.
Mean age of occurrence is 2 to 5 years.
It is a symptom complex manifested by massive oedema,
hypoalbuminemia, marked albuminuria and hyperlipidemia
5. 1. Congenital nephrotic syndrome
It is rare but serious and fatal problem usually associated with
other congenital abnormalities of kidney.
It is inherited as autosomal recessive disease.
Severe renal insufficiency and urinary infections along with
this condition result is poor prognosis.
2. Idiopathic or primary nephrotic syndrome
It is the most common type(about 90%) and regarded as autoimmune
phenomenon as it responds to immunosuppressive therapy.
Subgroup of this type
◦ Minimal change nephrotic syndrome(85%)
◦ Proliferative nephrotic syndrome(5%)
◦ Focal sclerosis nephrotic syndrome(10%)
6. 3. Secondary nephrotic syndrome
It occur in children about 10% of all cases.
This condition may occur due to some form of chronic
glomerularnephritis or due to diabetes mellites,systimic lupus
erythematosis(SLE), malaria,malignant hypertension, hepatitis
‘B’,infective endocarditis, drug toxicity, lymphomas and
syphilis
7. pathophysiology
The pathological changes of nephrotic syndrome may be
due to loss of charge selectivity and thickening of the foot
plate of the glomerular basement membrane.
These result in increased glomerular permiability which
permits the negatively charged protein, mainly albumin to
pass through the capillary walls into the urine.
Excess loss of albumin result in decrease in serum albumin
As a result of hypoalbuminemia,there is reduction in plasma
oncotic pressure.
8.
9. Thus fluid flows from the capillaries into the interstitial space and
produce oedma. The sift fo fluid from the plasma to the
interstitial spaces the intravascular fluid volume resulting
hypovolemia,which stimulate ranin angiotension axis and
volume receptor to secret aldosterone and antidiuretic hormone these
lead to reabsorption of Na & H2O in distal tubules
resulting oedema.
Loss of protein & immunoglobulin predisposes to infection in the child.
Diminished oncotic pressure leades to
hepatic lipoprotein synthesis which result
in hyperlipidemia.
10. Damaged glomerular capillary membrane
Loss of plasma protein (albumin)
HypoalbuminemiaStimulates synthesis of lipoproteins
Sodium retention
Generalized edema
(fluid moves from vascular space to
extracellular fluid)
Decreased oncotic pressure
Activation of renin–angiotensin system
Hyperlipidemia
Edema
11. 1. Child may present with periorbital
puffiness.
2. Oedema may be minimal or massive.
3. Profound weight gain with in a short
period.
4. Dependent oedema develops in the
ankle, feet, genitalia(scrotum) & hand.
5. Oedmatus part soft & pits easily on
pressure.
6. Striae may be appear on the skin due to
Fluid accumulate in the body space
resulting ascites,pleural effusion with
respiratory distress and generalized
oedema
7. Urine out put is reduce GI disturbances
usually found as vomiting, loss of appetite
& diarrhea
8. Other features include fatigue, lethergy,
pallor & irritability, hypertension,
hematuria, hepatomegaly & wasting of
muscle may found in some cases.
Clinical features
13. Demographic Details
NAME : حسن سعد حسنزعرب
ID:44052054
NUMBER :
D.O.B : 20/2/2018
GENDER : boy
AGE : 10 MONTH OLD
Ht:50cm
Wt:5kg
DATE AND TIME OF ADMISSION : 10/4/2018
DATE OF DISCHARGE: -
ADDRESS : الغربية .رفح
14. History of patient illness
Two month old male neonate product of NSVD , birth weight 2.8 kg ,
diagnosed anenataly with bilateral enlarged kidneys with history of
oligohydromnios , admitted after one week of birth to NIC Due to
generalized EDEMA ,The investigation show massive protein urea &low
total body protien,he had received multiple Albumin transfusion,
The parent are first cousin
The patint have 2 sobling healthy girls
No similar condition in the family
15. plan of therapy
1. H.albumin
2. Furosamid
3. Hydrocortison
4. Hypertonic normal
5. Salbutamol
6. L.Thyroxin
7. Alpha D3 0.25
8. Enalpril
9. CaCo3 600